A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: A stratification tool for prospective clinical trials

Journal of Urology

Volumn 174, Issue 5, 2005, Pages 1759-1763

  Leibovich, Bradley C ^a,b   Cheville, John C ^a   Lohse, Christine M ^a   Zincke, Horst ^a   Frank, Igor ^a   Kwon, Eugene D ^a   Merchan, Jaime R ^a   Blute, Michael L ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Carcinoma, renal cell; Kidney neoplasms; Neoplasm metastasis, survival

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; BONE METASTASIS; CANCER SURVIVAL; CLINICAL TRIAL; DEATH; FEMALE; HAZARD ASSESSMENT; HISTOLOGY; HUMAN; KIDNEY CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHRECTOMY; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; STRATIFICATION; SURVIVAL RATE; TIME SERIES ANALYSIS; TUMOR NECROSIS; TUMOR THROMBUS;

EID: 27544461925     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000177487.64651.3a     Document Type: Article

References (20)

1. Amin, M. B., Amin, M. B., Tamboli, P., Javidan, J., Stricker, H., de-Peralta Venturina, M. et al: Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol, 26: 281, 2002
2. Cheville, J. C., Lohse, C. M., Zincke, H., Weaver, A. L. and Blute, M. L.: Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol, 27: 612, 2003
3. Frank, I., Blute, M. L., Cheville, J. C., Lohse, C. M., Weaver, A. L. and Zincke, H.: An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade, and necrosis: the SSIGN score. J Urol, 168: 2395, 2002
4. Gelb, A. B.: Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer, 80: 981, 1997
5. Kattan, M. W., Reuter, V., Motzer, R. J., Katz, J. and Russo, P.: A postoperative prognostic nomogram for renal cell carcinoma. J Urol, 166: 63, 2001
6. Motzer, R. J., Mazumdar, M., Bacik, J., Berg, W., Amsterdam, A. and Ferrara, J.: Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol, 17: 2530, 1999
7. Pantuck, A. J., Zisman, A. and Belldegrun, A. S.: The changing natural history of renal cell carcinoma. J Urol, 166: 1611, 2001
8. Srigley, J. R., Hutter, R. V., Gelb, A. B., Henson, D. E., Kenney, G., King, B. F. et al: Current prognostic factors-renal cell carcinoma: Workgroup No. 4. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer, 80: 994, 1997
9. Zisman, A., Pantuck, A. J., Dorey, F., Said, J. W., Shvarts, O., Quintana, D. et al: Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol, 19: 1649, 2001
10. Storkel, S., Eble, J. N., Adlakha, K., Amin, M., Blute, M. L., Bostwick, D. G. et al: Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer, 80: 987, 1997
11. Leibovich, B. C., Blute, M. L., Cheville, J. C., Lohse, C. M., Frank, I., Kwon, E. D. et al: Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer, 97: 1663, 2003
12. Lohse, C. M., Blute, M. L., Zincke, H., Weaver, A. L. and Cheville, J. C.: Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients. Am J Clin Pathol, 118: 877, 2002
13. Cheville, J. C., Lohse, C. M., Zincke, H., Weaver, A. L., Leibovich, B. C., Frank, I. et al: Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol, 28: 435, 2004
14. Harrell, F. E., Jr., Lee, K. L. and Mark, D. B.: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med, 15: 361, 1996
15. Leibovich, B. C., Han, K. R., Bui, M. H., Pantuck, A. J., Dorey, F. J., Figlin, R. A. et al: Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer, 98: 2566, 2003
16. Kankuri, M., Pelliniemi, T. T., Pyrhonen, S., Nikkanen, V., Helenius, H. and Salminen, E.: Feasibility of prolonged use of interferon-alpha in metastatic kidney carcinoma: a phase II study. Cancer, 92: 761, 2001
17. van Herpen, C. M. and De Mulder, P. H.: Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinoma. Crit Rev Oncol Hematol, 41: 327, 2002
18. Han, K. R., Pantuck, A. J., Bui, M. H., Shvarts, O., Freitas, D. G., Zisman, A. et al: Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. Urology, 61: 314, 2003
19. Blute, M. L., Leibovich, B. C., Lohse, C. M., Cheville, J. C. and Zincke, H.: The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int, 94: 33, 2004
20. Moinzadeh, A. and Libertino, J. A.: Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same? J Urol, 171: 598, 2004